WHO Offers Technical Assistance To China On Joining PIC/S And Other Regulatory Issues
This article was originally published in SRA
The World Health Organization has signed a "regulatory cooperation plan" with the China Food and Drug Administration intended to help the CFDA strengthen its regulatory capabilities and to reinforce existing ties between the two organizations in a wide range of areas.
You may also be interested in...
A new pre-assessment service for COVID-19 clinical trials that was established by the UK medicines regulator to cut down on review times is being extended to a limited number of other kinds of trials.
The European Medicines Agency is developing a strategy to ensure that women have sufficient information to make informed choices about taking medicines during pregnancy and breastfeeding.
A first-of-its-kind collaborative study has found that real-world and natural history data are comparable to placebo data from clinical trials in Duchenne muscular dystrophy.